Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03162536
Title Safety, PK, PD, and Antitumor Activity of ARQ 531 in Hematologic Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors ArQule
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Hospital ( Site 0140) Scottsdale Arizona 85259 United States Details
UCLA Hematology & Oncology ( Site 0017) Los Angeles California 90095 United States Details
Colorado Blood Cancer Institute ( Site 0225) Denver Colorado 80218 United States Details
University of Michigan ( Site 0018) Ann Arbor Michigan 48109 United States Details
Mayo Clinic - Rochester ( Site 0138) Rochester Minnesota 58905 United States Details
Duke Cancer Center ( Site 0067) Durham North Carolina 27710 United States Details
The Ohio State University Wexner Medical Center ( Site 0056) Columbus Ohio 43210 United States Details
Tennessee Oncology, PLLC ( Site 0020) Nashville Tennessee 37203 United States Details
UT Southwestern Medical Center ( Site 0116) Dallas Texas 75390-8562 United States Details
University of Utah, Huntsman Cancer Institute ( Site 0122) Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field